Risk of development of diabetes mellitus after diagnosis of gestational diabetes

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 3, 2008, Pages 229-234

  Feig, Denice S ^a,b   Zinman, Bernard ^a,b   Wang, Xuesong ^c   Hux, Janet E ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PRIMARY MEDICAL CARE; RISK FACTOR; RURAL AREA; STATISTICAL SIGNIFICANCE;

EID: 48349118873     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.080012     Document Type: Article

References (35)

1. Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114-6.
2. Janssen PG, Gorter KJ, Stolk RP, et al. Low yield of population-based screening for type 2 diabetes in the Netherlands: the ADDITION Netherlands study. Fam Pract 2007;24:555-61.
3. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003:27 Suppl 2:S1-152.
4. American Diabetes Association. Standards of medical care in diabetes. II. Screening for diabetes. Diabetes Care 2007;30 Suppl 1:S5-7.
5. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med 2003;138:212-4.
6. Xiang AH, Peters RK, Trigo E, et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 1999;48:848-54.
7. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991;40 Suppl 2:131-5.
8. Albareda M, Caballero A, Badell G, et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003;26:1199-205.
9. Kim C, Newton K, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002;25:1862-8.
10. Damm P. Diabetes following gestational diabetes mellitus. In: Dornhorst A, Hadden DR, editors. Diabetes and pregnancy. Chichester (UK): Wiley; 1996. p. 341-50.
11. Schaefer-Graf UM, Buchanan TA, Xiang AH, et al. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002;186:751-6.
12. Xiang AH, Peters RK, Kjos SL, et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006;55:517-22.
13. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Finnish Diabetes Prevention Study. N Engl J Med 2001;344:1343-50.
14. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
15. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002;359:2072-7.
16. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-105.
17. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6.
18. Lobner K, Knopff A, Baumgarten A, et al. Predictors of postpartum diabetes in women with gestational diabetes. Diabetes 2006;55:792-7.
19. Kjos SL, Buchanan TA, Greenspoon JS, et al. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol 1990;163:93-8.
20. Mohamed N, Dooley J. Gestational diabetes and subsequent development of NIDDM in aboriginal women of northwestern Ontario. Int J Circumpolar Health 1998;57 Suppl 1:355-8.
21. Catalano PM, Vargo KM, Bernstein IM, et al. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991;165:914-9.
22. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991;5:461-83.
23. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.
24. Agresti A. Categorical data analysis. 2nd ed. New York: Wiley-Interscience; 2002.
25. Kjos SL, Peters R, Xiang A, et al. Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 1995;44:586-91.
26. Steinhart JR, Sugarman JR, Connell FA. Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM. Diabetes Care 1997;20:943-7.
27. Benjamin E, Mayfield J, Winters D, et al. Diabetes in pregnancy in Zuni Indian women: prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care 1993;16:1231-5.
28. Lee AJ, Hiscock RJ, Wein P, et al. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes. Diabetes Care 2007;30:878-83.
29. Russell C, Dodds L, Armson BA, et al. Diabetes mellitus following gestational diabetes: role of subsequent pregnancy. BJOG 2008;115:253-60.
30. Pallardo F, Herranz L, Garcia-Ingelmo T, et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999;22:1053-8.
31. Cundy T, Gamble G, Townend K, et al. Perinatal mortality in type 2 diabetes mellitus. Diabet Med 2000;17:33-9.
32. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001;86:989-93.
33. Lauenborg J, Hansen T, Moller Jensen D, et al. Increasing incidence of diabetes after gestational diabetes. Diabetes Care 2004;27:1194-9.
34. Dabelea D, Snell-Bergeon JK, Hartsfield CL, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort. Diabetes Care 2005;28:579-84.
35. Ferrara A, Kahn HS, Quesenberry CP, et al. An increase in the incidence of gestational diabetes mellitus: northern California, 1991-2000. Obstet Gynecol 2004;103:526-33.